TCR2 Therapeutics (TCRR) PT Lowered to $4 at Wedbush

May 12, 2022 1:27 PM EDT
Get Alerts TCRR Hot Sheet
Price: $2.89 -0.34%

Rating Summary:
    7 Buy, 3 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 1 | Down: 0 | New: 0
Join SI Premium – FREE
Wedbush analyst David Nierengarten lowered the price target on TCR2 Therapeutics (NASDAQ: TCRR) to $4.00 (from $8.00) while maintaining a Neutral rating.

You May Also Be Interested In





Related Categories

Analyst PT Change